BioNexus Gene Lab Debt to Equity Ratio 2019-2025 | BGLC
Current and historical debt to equity ratio values for BioNexus Gene Lab (BGLC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. BioNexus Gene Lab debt/equity for the three months ending March 31, 2025 was 0.00.
| BioNexus Gene Lab Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $0.00B | $0.01B | 0.22 |
| 2024-12-31 | $0.00B | $0.01B | 0.25 |
| 2024-09-30 | $0.00B | $0.01B | 0.17 |
| 2024-06-30 | $0.00B | $0.01B | 0.17 |
| 2024-03-31 | $0.00B | $0.01B | 0.19 |
| 2023-12-31 | $0.00B | $0.01B | 0.18 |
| 2023-09-30 | $0.00B | $0.01B | 0.18 |
| 2023-06-30 | $0.00B | $0.01B | 0.32 |
| 2023-03-31 | $0.00B | $0.01B | 0.25 |
| 2022-12-31 | $0.00B | $0.01B | 0.31 |
| 2022-09-30 | $0.00B | $0.01B | 0.21 |
| 2022-06-30 | $0.00B | $0.01B | 0.23 |
| 2022-03-31 | $0.00B | $0.01B | 0.29 |
| 2021-12-31 | $0.00B | $0.01B | 0.33 |
| 2021-09-30 | $0.00B | $0.01B | 0.39 |
| 2021-06-30 | $0.00B | $0.01B | 0.39 |
| 2021-03-31 | $0.00B | $0.01B | 0.46 |
| 2020-12-31 | $0.00B | $0.01B | 0.52 |
| 2020-09-30 | $0.00B | $0.00B | 0.09 |
| 2020-06-30 | $0.00B | $0.00B | 0.09 |
| 2020-03-31 | $0.00B | $0.00B | 0.09 |
| 2019-12-31 | $0.00B | $0.00B | 0.10 |
| 2019-09-30 | $0.00B | $0.00B | 0.06 |
| 2019-06-30 | $0.00B | $0.00B | 0.09 |
| 2019-03-31 | $0.00B | $0.00B | 0.09 |
| 2018-12-31 | $0.00B | $0.00B | 0.09 |
| 2018-09-30 | $0.00B | $0.00B | 0.00 |
| 2018-06-30 | $0.00B | $0.00B | 0.00 |
| 2018-03-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.007B | $0.010B |
| BioNexus Gene Lab Corp. is an emerging company in the business of selling chemical raw materials principally in the Southeast Asia region and the development of biopsy tests for early diagnosis and personalized health management. BioNexus Gene Lab Corp. is based in KUALA LUMPUR, Malaysia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.426B | 25.40 |
| Elevance Health (ELV) | United States | $85.189B | 10.99 |
| CVS Health (CVS) | United States | $80.455B | 10.00 |
| Cencora (COR) | United States | $56.610B | 19.69 |
| DiDi Global (DIDIY) | China | $22.073B | 33.50 |
| Natera (NTRA) | United States | $21.942B | 0.00 |
| BioMerieux (BMXMF) | France | $15.890B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.094B | 0.00 |
| Solventum (SOLV) | United States | $12.651B | 13.39 |
| CochLear (CHEOY) | Australia | $11.541B | 0.00 |
| Revvity (RVTY) | United States | $10.528B | 18.12 |
| ICON (ICLR) | Ireland | $10.410B | 9.68 |
| Viatris (VTRS) | United States | $10.199B | 3.50 |
| Doximity (DOCS) | United States | $9.673B | 44.78 |
| HealthEquity (HQY) | United States | $8.893B | 43.75 |
| Avantor (AVTR) | United States | $8.831B | 12.83 |
| Medpace Holdings (MEDP) | United States | $8.560B | 22.73 |
| Sonic Healthcare (SKHHY) | Australia | $8.409B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.633B | 13.00 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| BrightSpring Health Services (BTSG) | United States | $4.170B | 38.60 |
| Bausch + Lomb (BLCO) | Canada | $4.047B | 23.85 |
| Sotera Health (SHC) | United States | $3.460B | 19.66 |
| Alignment Healthcare (ALHC) | United States | $3.069B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.998B | 38.98 |
| Concentras Parent (CON) | United States | $2.754B | 15.92 |
| Organon (OGN) | United States | $2.405B | 2.56 |
| GeneDx Holdings (WGS) | United States | $2.115B | 81.46 |
| Ardent Health Partners (ARDT) | United States | $2.061B | 8.79 |
| Premier (PINC) | United States | $1.882B | 14.29 |
| Progyny (PGNY) | United States | $1.860B | 40.94 |
| PACS (PACS) | United States | $1.495B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.364B | 27.29 |
| Teladoc Health (TDOC) | United States | $1.205B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.163B | 8.85 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.982B | 0.00 | |
| CareDx (CDNA) | United States | $0.951B | 14.85 |
| Nutex Health (NUTX) | United States | $0.935B | 14.13 |
| Agilon Health (AGL) | United States | $0.931B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.777B | 7.28 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.611B | 4.11 |
| LifeMD (LFMD) | United States | $0.584B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.528B | 0.00 |
| Enhabit (EHAB) | United States | $0.525B | 43.21 |
| SBC Medicals (SBC) | United States | $0.484B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.482B | 10.85 |
| Sonida Senior Living (SNDA) | United States | $0.457B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.409B | 0.00 |
| Oncology Institute (TOI) | United States | $0.290B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.247B | 0.00 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| DocGo (DCGO) | United States | $0.152B | 24.83 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| KindlyMD (NAKA) | United States | $0.128B | 0.00 |
| So-Young (SY) | China | $0.092B | 0.00 |
| OncoCyte (OCX) | United States | $0.091B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.072B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.045B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.041B | 0.00 |
| ModivCare (MODV) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |